Schonfeld Strategic Advisors LLC Lexicon Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15 Billion
Q1 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 8,212,993 shares of LXRX stock, worth $6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,212,993

Previous 7,558,621 8.66%

Holding current value

$6 Million

Previous $5.59 Million 32.47%

% of portfolio

0.03%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.29 - $0.96 $189,767 - $628,197	654,372 Added 8.66%	8,212,993 $3.78 Million
Q4 2024 Feb 14, 2025	BUY	$0.65 - $2.08 $3.69 Million - $11.8 Million	5,676,021 Added 301.5%	7,558,621 $5.59 Million
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $1.98 Million - $3.13 Million	1,311,108 Added 229.42%	1,882,600 $2.96 Million
Q2 2024 Aug 14, 2024	SELL	$1.54 - $2.28 $598,533 - $886,140	-388,658 Reduced 40.48%	571,492 $960,000
Q1 2024 May 15, 2024	BUY	$1.3 - $3.58 $1.25 Million - $3.44 Million	960,150 New	960,150 $2.3 Million
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $24,884 - $54,699	-23,476 Reduced 4.76%	469,666 $511,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $718,405 - $1.17 Million	334,142 Added 210.15%	493,142 $1.13 Million
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $83,580 - $112,560	42,000 Added 35.9%	159,000 $386,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $210,600 - $299,520	117,000 New	117,000 $223,000
Q1 2021 May 17, 2021	SELL	$3.45 - $9.09 $261,165 - $688,113	-75,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $79,485 - $277,819	75,700 New	75,700 $259,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $138,399 - $193,790	-15,781 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $192,054 - $257,230	15,781	15,781 $194,000

Others Institutions Holding LXRX

# of Institutions

135

Shares Held

196M

Call Options Held

310K

Put Options Held

77.3K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $138M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Lexicon Pharmaceuticals, Inc. Transaction History